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Abstract 
Objectives: Oral submucous fibrosis (OSMF) is a potentially malignant disorder predominantly seen in the Indian 
subcontinent due to areca nut, tobacco and their products. The aim of the present study was to compare the efficacy 
of oxitard and aloe vera in the management of OSMF.
Material and Methods: 120 subjects with OSMF were included in the study. The patients were clinico-pathologi-
cally diagnosed and divided equally in 2 groups, Group A (oxitard group) and Group B (aloe vera group). Group A 
was administered 2 oxitard capsules twice daily and Group B was given 5 mg aloe vera gel to be applied topically 
thrice daily for 3 months. Different clinical parameters were evaluated at regular intervals. Data was analyzed using 
the Student’s paired t test and Chi-square test. P-value <0.001 was considered to be statistically significant. 
Results: Clinical improvements in mouth opening and tongue protrusion was significant in the oxitard group 
(p=0.0005). Subjective symptoms of pain associated with the lesion (p=0.0003), difficulty in swallowing (p=0.0000) 
and speech (p=0.0001) also significantly improved in the Group A. The improvement in burning sensation was not 
statistically significant between the 2 groups (p=0.002). There was a mild to moderate decrease in the size of the 
lesion. 
Conclusions: Though there is no definitive treatment for the condition however, overall assessment of symptoms 
like mouth opening, tongue protrusion, difficulty in swallowing and speech and pain associated with the lesion 
showed that oxitard capsules can bring about significant clinical improvements than aloe vera gel in the treatment 
of OSMF.
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Introduction
Oral submucous fibrosis [OSMF] is a high risk prema-
lignant condition of oral cavity, pharynx and upper di-
gestive tract, characterized by progressive inability to 
open the mouth and by inflammation and progressive 
fibrosis of the submucosal tissues (1). Susrutha descri-
bed a condition similar to OSMF as “vidari”, under the 
umbrella of mouth and throat diseases in ancient me-
dicine (2). Pindborg and his associates (3) defined the 
condition as “an insidious chronic disease affecting any 
part of the oral cavity and sometimes pharynx. Although 
occasionally preceded by and/or associated with vesicle 
formation, it is always associated with juxtaepithelial 
inflammatory reaction followed by fibroelastic changes 
in the lamina propria, with epithelial atrophy leading to 
stiffness of the oral mucosa causing trismus and difficul-
ty in eating.” The pathogenesis of the disease is not well 
known, but the etiology is believed to be multifactorial. 
The condition is particularly associated with chewing 
irritants such as areca nut, which is the main component 
of betel quid, tobacco and their numerous products. The 
habit of betel quid chewing is practiced predominately 
in the Indian subcontinent from a long time (1). These 
trigger the synthesis of collagen, tough fibrinous protein 
which causes stiffening of the soft mucous membrane 
and muscles of the oral cavity. The tongue usually esca-
pes as it is highly vascular. The mouth opening reduces 
and in extreme cases, only a button size opening is left 
(4). There is scarring with atrophy of the mucous mem-
brane and pain during swallowing. The atrophic mucous 
may ulcerate often, and subsequently may lead to ma-
lignancy (5).
Treatment modalities both medical and surgical, for re-
lieving the symptoms have been advocated, but have 
not been successful so far. Therefore, the search for an 
effective treatment modality still continues. Many na-
tural plants extracts, synthetic drugs, etc have been in-
troduced and tried for the management of OSMF. One 
such plant is aloe vera which promotes wound healing, 
and also has anti-inflammatory, immunomodulatory, 
and antioxidant properties (5). Oxitard is another her-
bal antioxidant formulation containing the extracts of 
Mangifera indica, Withania somnifera, Daucus carota, 
Glycyrrhiza glabra, Vitis vinifera, powders of Emblica 
officinalis and Yashada bhasma; and oils of Triticum sa-
tivum (6). The aim of the present study was to compare 
and evaluate the efficacy of herbal antioxidants oxitard 
and aloe vera in the management of OSMF.
Material and Methods 
The current prospective, randomized and single blind 
study included 120 OSMF patients reporting to the 
Department of Oral Medicine and Radiology, Jodhpur 
Dental College General Hospital. The patients were 
diagnosed clinically and histopathologically for OSMF. 
Patients of either sex with OSMF were included in the 
study. Ethical clearance was obtained from the Institu-
tional Ethical Committee. A written informed consent 
was obtained from the patients prior to the inclusion in 
the study. Patients who were not taking any medications 
for OSMF previously were included in the study. Those 
with any evidence of hypersensitivity to aloe vera, seve-
re psychiatric, cardiac, gastrointestinal or metabolic di-
sorders, pregnancy and lactation were excluded from the 
study. Detailed family and medical history and history of 
any associated habits and the course of the disease was 
recorded. A thorough clinical examination was carried 
out by oral medicine specialist and relevant findings were 
recorded. The subjects were also advised and encoura-
ged to quit the associated habit during the study period. 
The subjects were randomly divided in 2 equal groups, 
Group A [oxitard group] and Group B [aloe vera group]. 
Group A was administered 2 oxitard capsules twice daily 
and Group B was given 5 mg aloe vera gel [Sheetal Lab, 
Surat] to be applied topically thrice daily for 3 months 
and were further followed up for a period of 2 months. 
Patients were advised not to eat or drink for 15 minutes 
after the application of the aloe vera gel. Mouth opening 
was measured by measuring the distance between the 
centre of incisal edges of maxillary central incisors and 
mandibular central incisor at maximum opened mouth. 
In edentulous patients, the inter ridge [alveolar] distan-
ce along the midline was measured (7). Three measu-
rements were recorded consecutively and the average 
value was calculated and recorded. Tongue protrusion 
was measured as distance between lower central incisor 
and tip of the tongue on protrusion (7). Evaluation for 
presence, absence or reduction of other clinical parame-
ters such as burning sensation, pain associated with the 
lesion, difficulty in swallowing and speech and variation 
in the size of the lesion, which was assessed based on 
the blanching of the oral mucosa was done at regular in-
tervals of 1 month, 2 month and 3 months. The data was 
entered using computer software SPSS 12.0 [SPSS Inc., 
Chicago, USA] and analyzed using the Student’s paired 
t test and Chi-square test. P-value<0.001 was considered 
to be statistically significant. 
Results
There were 64 males and 56 females with a mean age 
of 31.6±12.7 years. 56% of the patients had habit of be-
tel nut chewing, while 26% of the patients had tobacco 
chewing habit. 40% of the patients consumed spicy fo-
ods which were among the main causative factors for 
OSMF in the study population. Clinical improvements 
in mouth opening and tongue protrusion was significant 
in the Group A [p=0.0005] (Table 1,2). The effect of ad-
ministration of oxitard capsules in the Group A showed 
significant improvement in the subjective symptoms 
of pain associated with the lesion [p=0.0003], difficul-
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ty in swallowing [p=0.0000] and speech [p=0.0001] 
when compared to the Group B who were given aloe 
vera (Table 3-5). However, there was no significant im-
provement in burning sensation [p=0.002] among the 2 
groups. There was a mild to moderate decrease in the 
size of the lesion. Nineteen patients of Group A and ten 
patients from Group B showed a severe degree of chan-
ge in the size of the lesion, i.e., a decrease of >2.5 cm. 
Twenty one patients from Group A and twenty one pa-
tients from Group B showed a moderate [1.5-2.5 cm] 
change in the size of the lesion at the end of the stu-
dy. Fifteen patients from Group A and ninteen patients 
from Group B showed a mild [0-1.5 cm] change in the 
size of the lesion. The improvement was not significant 
[p>0.001] among the 2 groups. However, five patients 
from Group A and ten patients from Group B showed 
no change in the lesion size over the study period. Eight 
patients experienced mild abdominal discomfort due to 
oxitard. There were no reported side effects. There were 
no dropouts from the study due to any reason during the 
follow-up. For oxitard group, during follow-up changes 
were similar to the results at the treatment except for 5 
cases that showed pain and burning sensation of oral ca-
vity for a period of 10 days. However, 16 patients from 
the aloe vera group reported pain, burning sensation and 
mild increase in the size of the lesion during the follow-
up period.
Oxitard Aloe vera p-value
Baseline 19.1±2.4 17.7±2.2
0.0005After 1 month 21.6±2.6 18.6±1.8
After 2 months 27.2±2.9 20.4±2.0
After 3 months 31.5±2.9 22.1±1.9
Table 1. Effect of oxitard and aloe vera in improving mouth opening (mean values in mm).
Oxitard Aloe vera p-value
Baseline 10.1±1.4 9.2±2.0
0.0005After 1 month 13.6±2.4 9.9±1.8
After 2 months 20.2±2.1 12.4±2.1
After 3 months 24.5±2.5 16.1±2.2
Table 2. Effect of oxitard and aloe vera in improving tongue protrusion (mean values in mm)
Oxitard Aloe vera
Present Absent Reduced Present Absent Reduced
Baseline 58 2 - 59 1 -
After 1 month 50 4 6 51 5 4
After 2 months 29 17 14 40 9 11
After 3 months 11 31 18 30 21 9
Table 3. Effect of oxitard and aloe vera on pain associated with the lesion.
Oxitard Aloe vera
Present Absent Reduced Present Absent Reduced
Baseline 57 3 - 59 1 -
After 1 month 38 10 12 52 4 4
After 2 months 24 22 14 41 10 9
After 3 months 7 36 17 26 21 13
Table 4. Effect of oxitard and aloe vera on difficulty in swallowing.
Table 5. Effect of oxitard and aloe vera on difficulty in speech.
Oxitard Aloe vera 
Present Absent Reduced Present Absent Reduced
Baseline 56 4 - 58 2 -
After 1 month 36 14 10 45 7 8
After 2 months 22 24 14 34 16 10
After 3 months 10 38 12 23 27 10
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Discussion
OSMF is a chronic disease of the oral cavity and 
oropharynx which is predominantly seen in the Indian 
subcontinent and Southeast Asian countries, commonly 
seen in the patients chewing arecanut and is now globa-
lly considered an Indian disease. The overall prevalence 
rate in India is estimated to be about 0.2% to 0.5% and 
prevalence by gender varying from 0.2-2.3% in males 
and 1.2-4.57% in females (8,9). It is considered to have 
a high degree of malignant potential, which ranges bet-
ween 2.3% and 7.6% (10). The condition is characterized 
by burning sensation of the oral mucosa, ulceration and 
pain, blanching of oral mucosa, reduced movement and 
depapillation of tongue, depigmentation of oral muco-
sa, and progressive reduction of mouth opening (11,12). 
Advanced stages of the condition may be characterized 
by nasal twang due to fibrosis of nasopharynx and hea-
ring impairment due to stenosis of eustachian tube. The 
pathophysiology is complex, and various factors such 
as, ingestion of chilies, genetic susceptibility, nutritional 
deficiencies, altered salivary constituents, autoimmunity 
and collagen disorders may be involved in the pathoge-
nesis (8). Areca nut and its products are the most com-
mon etiological factor. Majority of OSMF patients pre-
sent with irreversible moderate-to-severe condition. The 
changes of OSMF are limited to oral tissues and similar 
to those of scleroderma. It may be associated with oral 
leukoplakia and other potentially malignant disorders or 
with malignancy such as squamous cell carcinoma (11). 
The precancerous nature of OSMF has been proved by, 
higher occurrence of OSMF in oral squamous cell carci-
noma patients, histological diagnosis of cancer without 
any clinical suspicion in OSMF, high frequency of epi-
thelial dysplasia and higher prevalence of leukoplakia 
among OSMF. The debate over the initiation of malig-
nancy in OSMF due to epithelium or due to connective 
tissue is still unanswered (9,13). However, it has been 
suggested that the pathology develops within the epithe-
lium due to intraoral trauma and various factors such as, 
irritation from jagged teeth, sharp overhanging restora-
tion, ill-fitting dentures, jacket crowns, prolong use of 
tobacco and poor oral hygiene (14).
Many therapeutic and surgical treatment modalities for 
relieving the symptoms have been advocated, but no de-
finitive and widely accepted treatment is currently avai-
lable. The first step of preventive measure should be in 
advising the patient to discontinue the habit, which can 
be encouraged through education, counseling and advo-
cacy. Medical treatment includes steroids, placental ex-
tracts, IFN γ, lycopene, pentoxifylline, surgical excision, 
laser removal, etc. These have proved to be symptomatic 
and are predominantly aimed at improving mouth move-
ments. But each treatment has its own limitations. Ac-
cording to Caniif et al. (10) the medical management 
of OSMF is both empirical and unsatisfactory. Accor-
ding to Rehana et al. (15) multiple minerals and mi-
cronutrients showed significant improvement in mouth 
opening of 41% of the patients. Whereas, Borle et al. 
(16) showed improvement in symptoms of OSMF but 
insignificant improvement in mouth opening with vita-
min A. Lycopene has also showed significant improve-
ment in mouth opening in the study by Karemore et al. 
(17). Singh et al. have shown significant improvement in 
mouth opening, hyperkeratosis, pain in mouth and size 
of the lesion with oxitard capsules (6). Sudarshan et al. 
(18) have shown significant improvement in the mouth 
opening with aloe vera. No studies citing the comparati-
ve effectiveness specifically of oxitard and aloe vera in 
the treatment of OSMF have been done till date. Hence, 
the present study compared the efficacy of the 2 herbal 
antioxidants oxitard and aloe vera in the improvement 
of various clinical parameters such as, mouth opening, 
difficulty in swallowing, speech, pain associated with 
the lesion, tongue protrusion and burning sensation. 
The formulation of the oxitard capsules contains the 
extracts of Mangifera indica, Withania somnifera, Dau-
cus carota, Glycyrrhiza glabra, Vitis vinifera, powders 
of Emblica officinalis and Yashada bhasma; and oils of 
Triticum sativum. Mangifera indica is shown to have 
antibiotic, anti-asthamatic, antiseptic, antiviral, hypo-
tensive, anti-emetic properties. Withania somnifera 
provides overall health and wellness with its anti-stress, 
anti-anxiety, anti-inflammatory, anti-convulsive and 
anti-arthritic properties. Daucus carota acts as a good 
antiseptic as it is a rich source of vitamin A. Glycyrr-
hiza glabra normalizes the hoarseness in voice and has 
immunomodulatory and anti-inflammatory properties. 
Vitis vinifera have anti-inflammatory, astringent and an 
effect to curb the burning sensation. Emblica officinalis 
is a rich source of vitamin C and is a potent antibiotic. 
Yashada bhasma contains zinc which plays a significant 
role in protein synthesis, cell division and wound hea-
ling. Triticum sativum is a rich source of minerals and 
has an antioxidant property (6).
Aloe vera is a mannoprotein containing many amino 
acids known as ‘wound healing hormones’. The po-
lysaccharides contained in the gel of the leaves, promote 
wound healing, and have anti-inflammatory, immuno-
modulatory, antioxidant properties and gastro protective 
properties. Further, sterols in the Aloe vera have strong 
ability to inhibit inflammation similar to the action of 
cortisone without any side effects. It can be found easily 
and is of low cost in India (18).
Till date, no treatment protocol has been formulated to 
restore the mouth opening to normal; however an im-
provement of a few millimeters has been observed. The 
present study showed improvement in both the groups 
at the end of the study. The results were much better in 
the oxitard group when compared to the patients who 
were advised to apply aloe vera gel locally. There were 
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significant improvements in mouth opening [p=0.0005], 
tongue protrusion [p-0.0005], pain associated with the 
lesion [p=0.0003], difficulty in swallowing [p=0.0000] 
and speech [p=0.0001] in the oxitard group when com-
pared to the aloe vera group. However, the improve-
ments in burning sensation were not statistically signi-
ficant [p=0.002].
The present study showed that mouth opening impro-
ved 60.5% in Group A, whereas Group B showed 25% 
improvement. This was not in line with the findings of 
Sudarshan et al. (18) who showed an improvement of 
20% in the patients who were given aloe vera, whereas 
those who were given antioxidants showed an improve-
ment of only 9%, which was much lower than the fin-
dings of the present study. Singh et al. (6) showed a sig-
nificant [p<0.05] improvement in mouth opening with 
oxitard capsules. Sudarshan et al. (18) showed an im-
provement of 80% in burning sensation in the aloe vera 
group whereas 65.7% patients showed in the antioxidant 
group showed improvement in burning sensation. This 
difference was statistically significant [p=0.008], in con-
trast to the findings of the present study where the di-
fference in the improvement in both the groups was not 
statistically significant [p=0.002]. Biweekly submucosal 
injection for a period of 10 weeks with dexamethasone 
[4 mg], hyaluronidase [1500 IU], and placental extracts 
[2 ml] also showed similar results in the 82%, 82%, 
51%  reduction in burning sensation, respectively (19). 
Improvement in tongue protrusion was significantly 
[p=0.0005] higher in the Group A than Group B. Su-
darshan et al. (18) showed an improvement of 8.8% in 
the aloe vera group while the antioxidant group showed 
4.25% improvement. 
The present study also showed a significant improvement 
in the pain associated with the lesion [p=0.0003], diffi-
culty in swallowing [p=0.0000] and speech [p=0.0001]. 
Thirty one patients in the Group A and 21 patients in 
Group B showed complete absence of pain at the end 
of the treatment. While in the study conducted by Singh 
et al. (6) none of the patients who were administered 
oxitard capsules showed severe degree of pain in OSMF 
patients. Only 7 patients in Group A had difficulty in 
swallowing at the end of the study, whereas 26 patients 
still complained of difficulty while swallowing in Group 
B. Ten patients in Group A complained of difficulty in 
speech, while 26 patients in Group B had persistent 
difficulty in speech at the end of 3 months. There was 
a mild to moderate decrease in the size of the lesion. 
Ninteen patients of Group A and 10 patients from Group 
B showed a severe degree of change in the size of the 
lesion. 21 patients from both the groups showed a mo-
derate [1.5-2.5 cm] change in the size of the lesion at the 
end of the study. Fifteen patients from Group A and 19 
patients from Group B showed a mild [0-1.5 cm] chan-
ge in the size of the lesion. Five patients from Group A 
and 10 patients from Group B showed no change in the 
lesion size at the end of 3 months. The study conducted 
by Singh et al. (6) showed that 29 patients showed no 
improvement at the end of the study, while only 3 pa-
tients showed severe [>2 cm] improvement in the size 
of the lesion. 
Oxitard has shown significant improvement in mouth 
opening, tongue protrusion, pain with the lesion, diffi-
culty in swallowing and speech when compared to aloe 
vera. Aloe vera has shown anti-inflammatory properties 
over a wide range of experiments. The sterols in Aloe 
have strong anti-inflammatory properties, similar to 
cortisone, without any of the side effects. The fact that 
aloe works similar to aspirin in blocking prostaglan-
din effects, still remains to be proven. Aloe vera can be 
applied topically, is easily available, safe to use, cost 
effective, non-invasive and effective treatment modality 
for OSMF. Both the medicaments can be considered to 
be an effectual protocol in the management of OSMF. 
However, the results with oxitard capsules were signi-
ficantly better than the aloe vera group. Quitting of the 
habit alone as an intervention may have a significantly 
greater effect, on the symptoms of OSMF. Hence, inter-
vention studies and public health campaigns at the com-
munity level may be the best way of controlling OSMF.
References
1. Cox SC, Walker DM. Oral submucous fibrosis. A review. Aust Dent 
J. 1996;41:294-9.
2. Kale AD, Mane DR, Shukla D. Expression of transforming growth 
factor â and its correlation with lipodystrophy in oral submucous 
fibrosis: an immunohistochemical study. Med Oral Patol Oral Cir 
Bucal. 2013;18:e12-8.
3. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral 
Med Oral Pathol. 1966;22:764-79.
4. Cox XC, Walker DM. Establishing a normal range for mouth ope-
ning: Its use in screening for oral submucous fibrosis. Br J Oral 
Maxillofac Surg. 1997;35:40-2.
5. Ramadass T, Manokaran G, Pushpala SM, Narayanan N, Kulkarni 
GN. Oral submucous fibrosis- New dimensions in surgery. Indian J 
Otolaryngol Head Neck Surg. 2005;57:99-102.
6. Singh BP, Mittal N, Sharma V, Palani. Evaluation of role of oxitard 
capsules in the treatment of oral submucous fibrosis. The Antiseptic. 
2009;106:103-7.
7. Rajendran R, Rani V, Shaikh S. Pentoxifylline therapy: a new ad-
junct in the treatment of oral submucous fibrosis. Indian J Dent Res. 
2006;17:190-8.
8. Khan S, Chatra L, Prashanth SK, Veena KM, Rao PK. Pathogenesis 
of oral submucous fibrosis. J Cancer Res Ther. 2012;8:199-203.
9. Yoithapprabhunath TR, Maheswaran T, Dineshshankar J, Anusus-
hanth A, Sindhuja P,  Sitra G. Pathogenesis and therapeutic in-
tervention of oral submucous fibrosis. J Pharm Bioallied Sci. 
2013;5:S85-S8.
10. Canniff JP, Harvey W. The aetiology of oral submucous fibrosis: 
the stimulation of collagen synthesis by extracts of areca nut. Int J 
Oral Surg. 1981;10:163-7.
11. More CB, Das S, Patel H, Adalja C, Kamatchi V, Venkatesh R. 
Proposed clinical classification for oral submucous fibrosis. Oral 
Oncol. 2012;48:200-2.
12. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakula-
e270
J Clin Exp Dent. 2014;6(3):e265-70. Comparative efficacy of oxitard and aloe vera in OSMF
suriya S. Oral submucous fibrosis: review on aetiology and patho-
genesis. Oral Oncol. 2006;42:561-8.
13. Pindborg JJ. Is submucous fibrosis a precancerous condition in the 
oral cavity? Int Dent J. 1972;22:474-80.
14. Dayal, Reddy R, Anuradha Bhat K. Malignant potential of oral 
submucous fibrosis due to intraoral trauma. Indian J Med Sci. 
2000;54:182-7.
15. Maher R, Aga P, Johnson NW, Sankaranarayanan R, Warnakula-
suriya S. Evaluation of multiple micronutrient supplementation in 
the management of oral submucous fibrosis in Karachi, Pakistan. 
Nutr Cancer. 1997;27:41-7.
16. Borle RM, Borle SR. Management of oral submucous fibrosis: a 
conservative approach. J Oral Maxillofac Surg. 1991;49:788-91.
17. Karemore TV, Motwani M. Evaluation of the effect of newer an-
tioxidant lycopene in the treatment of oral submucous fibrosis. In-
dian J Dent Res. 2012;23:524-8.
18. Sudarshan R, Annigeri RG, Sree Vijayabala G. Aloe vera in the 
treatment for oral submucous fibrosis- a preliminary study. J Oral 
Pathol Med. 2012;41:755-61.
19. Gupta D, Sharma SC. Oral submucous fibrosis: a new treatment 
regimen. J Oral Maxillofac Surg. 1988;46:830-3.
Conflict of Interest
As far as the authors are aware there was no conflict of interests.
